fda warning letters glp-1 compounders october 2025 U.S. on X: "FDA issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's September crackdown on misleading FDA Issues Warning Letters Against

The wellness industry commonly uses sly marketing to sell products of dubious effectiveness, but theres something especially unnerving about its attempt to move into the obesity-drug space

Embrace the transformation as your skin feels refreshed and revitalised, and watch as your natural radiance shines through like never before

Compare the monthly and five-year cost Use our free cost comparison tool below to see what each medication costs

WHO-GMP Certified Injectable Facility Produced in a sterile, state-of-the-art plant with full QA/QC compliance

Grounded in mechanism

The clinical profile of BPC-157, including how it compares to TB-500 and when the two are combined at our Doral clinic, is in our complete BPC-157 guide